Raymond Pratt - 21 Nov 2022 Form 4 Insider Report for Savara Inc (SVRA)

Role
Chief Medical Officer
Signature
/s/ Kathleen McCabe as attorney-in-fact for Raymond D. Pratt
Issuer symbol
SVRA
Transactions as of
21 Nov 2022
Net transactions value
$0
Form type
4
Filing time
22 Nov 2022, 15:08:44 UTC
Previous filing
16 Nov 2022
Next filing
22 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SVRA Common Stock Award $0 +150,000 $0.000000 150,000 21 Nov 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SVRA Stock Option (Right to Buy) Award $0 +375,000 $0.000000 375,000 21 Nov 2022 Common Stock 375,000 $1.43 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") that vest in full on November 10, 2024, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2 The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of November 10, 2022, subject to the reporting person's continued service with the Issuer.